{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:44:12Z","timestamp":1768805052406,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jneuroim.2011.12.009","type":"journal-article","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T20:42:09Z","timestamp":1325796129000},"page":"103-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab"],"prefix":"10.1016","volume":"243","author":[{"given":"Patricia","family":"Mulero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Bel\u00e9n","family":"Caminero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Jos\u00e9","family":"Neri Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Fern\u00e1ndez-Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"T\u00e9llez Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jneuroim.2011.12.009_bb0005","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cgh.2007.04.007","article-title":"Risk for active tuberculosis in inflammatory bowel disease patients","volume":"5","author":"Aberra","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jneuroim.2011.12.009_bb0010","unstructured":"Biogen Indec, post-marketing data on file."},{"issue":"6","key":"10.1016\/j.jneuroim.2011.12.009_bb0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumour necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.jneuroim.2011.12.009_bb0020","first-page":"1436","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis","volume":"30","author":"Carmona","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2011.12.009_bb0025","author":"European Medicines Agency"},{"issue":"9","key":"10.1016\/j.jneuroim.2011.12.009_bb0030","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.164.9.4853","article-title":"Up-regulation of VCAM-1 and differential expansion of \u03b2 integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection","volume":"164","author":"Feng","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.12.009_bb0035","first-page":"1779","article-title":"Tuberculosis infections and tumor necrosis factor alpha antagonists","volume":"124","author":"Gan","year":"2011","journal-title":"Am. J. Ther."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2011.12.009_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jneuroim.2007.04.006","article-title":"Expert opinion: guidelines for the use of natalizumab in mutiple sclerosis patients previously treated with immunomodulating therapies","volume":"187","author":"Gold","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.jneuroim.2011.12.009_bb0045","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jneuroim.2011.12.009_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","article-title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","volume":"10","author":"Kappos","year":"2011","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2011.12.009_bb0055","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.160.10.1513","article-title":"Benefits of screening for latent Mycobacterium tuberculosis infection","volume":"160","author":"Rose","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.jneuroim.2011.12.009_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1157\/13126836","article-title":"Diagnosis and treatment of tuberculosis","volume":"44","author":"Ruiz-Manzano","year":"2008","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.jneuroim.2011.12.009_bb0065","unstructured":"Tuberculosis surveillance in Europe. (Web: www.ecdc.europa.eu)"},{"key":"10.1016\/j.jneuroim.2011.12.009_bb0075","author":"World Health Organization"},{"issue":"9","key":"10.1016\/j.jneuroim.2011.12.009_bb0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","article-title":"Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy","volume":"354","author":"Yousry","year":"2006","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811003614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811003614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:11Z","timestamp":1759047491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572811003614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0165572811003614"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.12.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}